TSP Capital Management Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-7,875
Closed -$6.5M 46
2025
Q1
$6.5M Sell
7,875
-6,365
-45% -$5.3M 2.14% 19
2024
Q4
$11M Sell
14,240
-4,435
-24% -$3.67M 3.73% 12
2024
Q3
$16.5M Sell
18,675
-110
-0.6% -$98.9K 5.12% 5
2024
Q2
$17M Sell
18,785
-1,565
-8% -$1.25M 5.33% 5
2024
Q1
$15.8M Sell
20,350
-50
-0.2% -$35.6K 5.1% 5
2023
Q4
$11.9M Sell
20,400
-1,500
-7% -$876K 4.12% 9
2023
Q3
$11.8M Sell
21,900
-4,960
-18% -$2.56M 4.54% 5
2023
Q2
$12.6M Sell
26,860
-7,575
-22% -$3.18M 4.55% 8
2023
Q1
$11.8M Sell
34,435
-2,800
-8% -$944K 4.27% 8
2022
Q4
$13.6M Buy
+37,235
New +$13.2M 5.1% 2
2022
Q3
Hold
0
3
2022
Q2
Hold
0
4
2022
Q1
Hold
0
9
2021
Q4
Hold
0
10
2021
Q3
Hold
0
12
2021
Q2
Sell
-47,971
Closed -$9.64M 13
2021
Q1
$8.96M Sell
47,971
-100
-0.2% -$19.6K 3.16% 13
2020
Q4
$8.12M Buy
+48,071
New +$7.18M 2.88% 16
2020
Q3
Hold
0
17
2020
Q2
Hold
0
13
2020
Q1
Hold
0
9
2019
Q4
Hold
0
8
2019
Q3
Hold
0
10
2019
Q2
Hold
0
10
2019
Q1
Sell
-68,552
Closed -$8.34M 5
2018
Q4
$7.93M Buy
+68,552
New +$7.66M 4.45% 5
2018
Q3
Sell
-69,727
Closed -$6.97M 6
2018
Q2
$5.95M Sell
69,727
-1,000
-1% -$82.1K 3.05% 13
2018
Q1
$5.47M Sell
70,727
-100
-0.1% -$8.05K 2.61% 15
2017
Q4
$5.98M Hold
70,827
2.72% 14
2017
Q3
$6.06M Buy
+70,827
New +$5.81M 2.89% 14
2017
Q2
Hold
0
14
2017
Q1
Hold
0
12
2016
Q4
Hold
0
14
2016
Q3
Sell
-73,134
Closed -$5.85M 14
2016
Q2
$5.76M Sell
73,134
-100
-0.1% -$7.53K 2.98% 14
2016
Q1
$5.27M Sell
73,234
-2,008
-3% -$152K 2.9% 13
2015
Q4
$6.34M Sell
75,242
-697
-0.9% -$57.8K 3.39% 10
2015
Q3
$6.36M Sell
75,939
-16,346
-18% -$1.38M 3.57% 10
2015
Q2
$7.71M Buy
+92,285
New +$7.03M 3.58% 7
2015
Q1
Hold
0
7
2014
Q4
Hold
0
7
2014
Q3
Sell
-119,345
Closed -$7.56M 9
2014
Q2
$7.42M Buy
+119,345
New +$7.12M 3.22% 10
2014
Q1
Hold
0
10
2013
Q4
Hold
0
13
2013
Q3
Hold
0
10
2013
Q2
Hold
0
11

Other funds holding LLY

TSP Capital Management Group's LLY Position: Q2 2025 in Review

TSP Capital Management Group sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 7,875 shares — an estimated $6.5M sold.

TSP Capital Management Group first reported a position in LLY in Q2 2014 and held it in 23 quarters. The position peaked at $17M in Q2 2024. 3,906 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • TSP Capital Management Group reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
  • TSP Capital Management Group sold 7,875 Eli Lilly shares in Q2 2025, an estimated $6.5M.
  • TSP Capital Management Group first reported a position in Eli Lilly in Q2 2014 and held it in 23 quarters.
  • TSP Capital Management Group's Eli Lilly position peaked at $17M in Q2 2024.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on TSP Capital Management Group's 13F filing for Q2 2025, filed 11 Aug 2025.